Drug intelligence / Profile preview

Exsept Plus

Development stage
Unknown
Lead developer
Angelini Pharma
Modality
Small Molecules
Administration
Topical
01

Overview

**Exsept Plus** is a topical antimicrobial wound and skin cleanser developed by Angelini Pharma and manufactured by A.C.R.A.F. in Italy. It is an aqueous **small-molecule antiseptic solution** containing sodium hypochlorite at approximately 0.11% to 0.114% with sodium chloride 1.7% in purified water. The product is intended for topical skin antisepsis and wound cleansing, including skin site preparation before injection, instrument use, or dialysis, as well as catheter exit-site cleaning. Its antimicrobial effect is mediated by hypochlorite-driven oxidative microbicidal activity, providing broad-spectrum activity against bacteria, fungi, and viruses, including reported activity against *Staphylococcus aureus*, *Streptococcus faecalis*, *Pseudomonas aeruginosa*, MRSA, and VRE. It is positioned as an iodine alternative for skin antisepsis and is described as non-cytotoxic, non-irritating, non-sensitizing, and non-allergenic.

Brand names
Exsept Plus
Other names
sodium hypochlorite topical solutionsodium hypochlorite 0.11% solution

Beyond the preview

Go deeper on Exsept Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exsept Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call